Primaquine for uncomplicated Plasmodium vivax malaria in children younger than 15 years: a systematic review and individual patient data meta-analysis
Journal article
Commons RJ. et al, (2024), The Lancet Child & Adolescent Health, 8, 798 - 808
Methaemoglobin as a surrogate marker of primaquine antihypnozoite activity in Plasmodium vivax malaria: A systematic review and individual patient data meta-analysis.
Journal article
Fadilah I. et al, (2024), PLoS medicine, 21
Lineage-informative microhaplotypes for recurrence classification and spatio-temporal surveillance of Plasmodium vivax malaria parasites
Journal article
Siegel SV. et al, (2024), Nature Communications, 15
Implementation of Glucose-6-Phosphate Dehydrogenase (G6PD) testing for Plasmodium vivax case management, a mixed method study from Cambodia
Journal article
Cassidy-Seyoum SA. et al, (2024), PLOS Global Public Health, 4, e0003476 - e0003476
Chloroquine has shown high therapeutic efficacy against uncomplicated Plasmodium vivax malaria in southern Ethiopia: seven decades after its introduction.
Journal article
Mare AK. et al, (2024), Malaria journal, 23
The PreQuine Platform: A novel diagnostic tool for measuring glucose-6-phosphate dehydrogenase (G6PD) activity and hemoglobin concentration
Journal article
Harper R. et al, (2024), PLOS ONE, 19, e0297918 - e0297918
On-target, dual aminopeptidase inhibition provides cross-species antimalarial activity.
Journal article
Edgar RCS. et al, (2024), mBio
Evidence uptake is only part of the process: Stakeholders’ insights on WHO treatment guideline recommendation processes for radical cure of P. vivax malaria
Journal article
Ruwanpura VSH. et al, (2024), PLOS Global Public Health, 4, e0002990 - e0002990
Progress towards safer and more effective radical cure of Plasmodium vivax.
Journal article
Price RN., (2024), The Lancet. Infectious diseases
Response to comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis'
Journal article
Watson JA. et al, (2024), eLife, 13
A randomised controlled trial to compare the efficacy, safety, and tolerability of low dose, short course primaquine in adults with uncomplicated P. vivax malaria in two hospitals in India.
Journal article
Ahmad SS. et al, (2024), Trials, 25
Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis
Journal article
Commons RJ. et al, (2024), The Lancet Infectious Diseases, 24, 172 - 183
Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis
Journal article
Rajasekhar M. et al, (2024), The Lancet Infectious Diseases, 24, 184 - 195
Field assessment of the operating procedures of a semi-quantitative G6PD Biosensor to improve repeatability of routine testing
Journal article
Sadhewa A. et al, (2024), PLOS ONE, 19, e0296708 - e0296708
Field evaluation of a novel semi-quantitative point-of-care diagnostic for G6PD deficiency in Indonesia.
Journal article
Sadhewa A. et al, (2024), PloS one, 19
Imported malaria into Australia: surveillance insights and opportunities
Journal article
Sohail A. et al, (2023), Journal of Travel Medicine
Safety and efficacy of primaquine in patients withPlasmodium vivaxmalaria from South Asia: a systematic review and individual patient data meta-analysis
Journal article
Verma R. et al, (2023), BMJ Global Health, 8, e012675 - e012675
The feasibility of novel point-of-care diagnostics for febrile illnesses at health centres in Southeast Asia: a mixed-methods study
Journal article
Adella FJ. et al, (2023), Transactions of The Royal Society of Tropical Medicine and Hygiene, 117, 788 - 796
Genomic analysis of Plasmodium vivax describes patterns of connectivity and putative drivers of adaptation in Ethiopia.
Journal article
Kebede AM. et al, (2023), Scientific reports, 13